A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...

As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...

Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

The current administration has pulled millions in HIV-related grants and cut staffing positions essential to research and ...

Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new ...

Eight times more American young adults now take medication to protect them from HIV than a decade ago, a new study finds.

Nina E. Hill, MD, from the University of Michigan in Ann Arbor, and colleagues examined recent trends in HIV PrEP among young adults (aged 18 to 25 years). The analysis included data from the IQVIA ...

In Philippi village in the Western Cape of South Africa, 24-year-old Simamkele Matinise works at an HIV-prevention mobile ...

HIV and other STIs every three to six months. Even patients who decide to take their PrEP pills on an episodic rather than ...

UConn Health in Farmington has been working to reach underserved populations and educate them about PrEP for HIV. PrEP, or ...

It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...